【文章內(nèi)容簡介】 增加有氧訓(xùn)練的強度并不能增加治療作用。參考文獻[1]葉志中，李博，何偉珍，主編．兒童風(fēng)濕病學(xué)．北京：人民衛(wèi)生出版社，2009：3536，l 2 j Manners PJ，Bower C．Worldwide prevalence of juvenile arthritis．why does it vary so much?J Rheumatology，2002，29：1520—1530．1 3 j Arguedas O，F(xiàn)asth A，AnderssonG￡ire B，et a1．Juvenile chronicarthritis in urban San Jos6，Costa Rica：a 2 year prospectivestudy．J Rheumatol，1998，25：18441850．[4]覃肇源，蔣小云，林育權(quán)，等．幼年特發(fā)性關(guān)節(jié)炎228例．實用兒科臨床雜志，2008，23：1663．1665．[5]甄小芳，馬嵩春，幺遠(yuǎn)，等．幼年類風(fēng)濕性關(guān)節(jié)炎96例的預(yù)后和轉(zhuǎn)歸．實用兒科臨床雜志，2004，19：201203．[6 j Petty RE，Southwood TR，Manners P，et a1．International leagueof associations of rheumatology classification of iuvenile idiopathicarthritis：second revision，Edmonton．2001．J Rheumatol，2004．31：390392．[7]何曉琥．幼年特發(fā)性關(guān)節(jié)炎．加拿大埃德蒙頓2001年國際風(fēng)濕病學(xué)聯(lián)盟新的分類標(biāo)準(zhǔn)討論稿．中華風(fēng)濕病雜志，2002，6：62．63．8】Ravelli A，F(xiàn)elici E，MagniManzoni S，et a1．Patients withantinuclear antibody—positive iuvenile idiopathic arthritis constitutea homogeneous subgroup irrespective of the eonrse of joint disease．Arthritis Rheum，2005，52：826—832．9 Avcin T，Cimaz R，F(xiàn)alcini F，et a1．Prevalence and clinicalsignificance of anti．cyclic eitrnllinated peptide antibodies injuvenile idiopathic arthritis，Ann Rheum Dis，2002，61：60861 1．1 10]Ferucci ED，Majka DS，Parrish LA，et a1．Antibodies againstcyclic citrnllinated peptide are associated with HLA—DR4 insimplex and multiplex polyarticularonset juvenile rheumatoidarthritis．Arthritis Rheum，2005，52：239246．1 1 Nesher G。Moore TL，Grisanti MW，et a1．Antiperinuclear factorin iuvenile rheumatoid arthritis．Ann Rheum Dis，1992，5 1：350．352．[12]Gabay C，Prieur AM，Meyer O．Occurrence of antiperinuelear，antikeratin，and antiRA33 antibodies in juvenile chronic arthritis．Ann Rheum Dis，1993，52：785789．[13]李永柏，胡堅，整理．巨噬細(xì)胞活化綜合征專題討論會紀(jì)要，中華兒科雜志，2006，44：831．832．[14]Van Rossum MA，Boers M，Zwinderman AH，et a1．Development ofa standardized method of assessment of radiographs andradiographic change in juvenile idiopathic arthritis：introduction ofthe dijkstra posite score．Arthritis Rheum，2005，52：2865—2872．[15]Gylys—Morin VM，Graham TB，Blebea JS，et a1．Knee in earlyjuvenile rheumatoid arthritis：MR imaging findings．Radiology，2001，220：696706．[16]王崢嶸，張玉林，蘇英姿，等．膝關(guān)節(jié)超聲檢查在幼年類風(fēng)濕性關(guān)節(jié)炎診斷中的價值．實用兒科臨床雜志．2004，19：660661．17 Carrasco R，Lovell DJ，Giannini EH。et a1．Biochemical markers ofbone turnover associated with calcium supplementation in childrenwith juvenile rheumatoid arthritis．Arthritis Rheum，2008，58：39323940．[1 8]Giannini EH，Ruperto N，Ravelli A，et a1．Preliminary definition ofimprovement in juvenile arthritis．Arthritis Rheumatism，1997，40：1202—1209．19 Prevoo ML，vail’t Hof MA，Kuper HH，et a1．Modified diseaseactivity scores that include twentyeightjoint counts．Developmentand validation in a prospective longitudinal study of patients withrheumatoid arthritis．Arthritis Rheum，1995，38：4448．[20]Beukelman T，Patkar NM，Saag KG，et a1．2011 American Collegeof Rheumatology remendations for the treatment of iuvenileidiopathic arthritis：initiation and safety monitoring of therapeuticagents for the treatment of arthritis and systemic foatures．ArthritisCare Res(Hoboken)，201 l，63：465482．[21]Ruperto N，Nikishina I，Pachanov ED，et a1．A Randomized，double—Blind clinical trial of two doses of meloxicam pared withn即roxen in children with iuvenile idiopathic arthritis．Short—andlongterm efficacy and safety results．Arthritis Rheumatism，2005，52：563572．[22]Giannini EH，Brewer EJ，Miller ML，et a1．Ibuprofen suspension inthe treatment of juvenile rheumatoid arthritis．PediatricRheumatology Collaborative Study Group．J Pediatr，1990，117：645652．[23]Ailioaie C，Lupu167。oru—Ailioaie LM．Antirheumatic effeets of first—line agents in the treatment of iuvenile chronic arthritis．Rev MedChir Soc Med Nat Iasi，1997，101：134．138．[24]Hashkes PJ，Laxer RM．Medical treatment of juvenile idiopathicarthritis．JAMA，2005，294：1671—1684．25 Josef S Smolen，Robert Landew6，F(xiàn)erdinand C．et a1．EULARremendations for th